Clinical case of resistant AML (FAB-M2) with FLT3-ITD mutation. Bone marrow morphology: 23% blasts, dyserythropoiesis, micromegakaryocytes.
Acute myeloid leukemia, (M2), resistant course Material - bone marrow. The patient underwent 2 courses of chemotherapy without achieving remission; an ITD mutation in the FLT3 gene was detected. A third course of therapy has been initiated. In the myelogram, blasts up to 23% are found, micromegakaryocytes are present, and signs of dyserythropoiesis are noted in the erythroid lineage - intererythroid cytoplasmic bridges.
🙏 The publication was kindly provided by Ekaterina Nozdrina, Omsk.
Clinical case of MDS transforming to AML: 43% blasts, pronounced clasmatosis, signs of dyserythropoiesis, and cytochemical bone marrow results.
Clinical case of acute myeloid leukemia: bone marrow blast morphology and multinucleated erythroblasts as a sign of dyserythropoiesis.
Cytological findings of bone marrow aspirate after AML treatment: hypocellularity, rare blasts, macrophages, and immature megakaryocytes.
